$CME

CME Group earnings analysis: questions answered and next catalysts

CME Group reported Q3 2026 earnings with revenue of $1.74B and EPS of $3.02, both slightly above estimates. Shares were up 0.27% at $296.12. Volume demand was strong across all asset classes, with international growth notable. The company returned nearly $1B to shareholders. Next catalysts include the launch of CME Securities Clearing and Q4 earnings.

Original reporting
Published Oct 21, 2026, 4:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 4:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CME
Neutral
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CMENeutralHigh
01

Why it matters

The earnings release confirms record volume and continued buyback activity, but the small beat may limit upside momentum.

02

Market read

Earnings data provides fresh guidance for traders in futures, clearing and market‑data space.

03

What to watch

The upcoming CME Securities Clearing launch and cloud migration to Google could drive longer‑term revenue growth.

Relevance 8/10Novelty 8/10Timing: today, post‑earnings release

Background

CME Group is the world’s largest derivatives clearinghouse; its earnings are closely watched for market‑wide liquidity trends.

Company-level read

Ticker impact

$CMENeutralHigh confidence
Context

CME Group reported Q3 2026 earnings with a modest beat and record volume, providing fresh guidance and buyback details.

Expected impact

likely modest downside as market prices in the modest beat and high expectations

Evidence & confidence

The beat was only 1.3% on EPS and the stock had already risen 24% over three months; investors may trim positions.

Market effects

Higher clearing volume supports bullish outlook for exchange‑traded derivatives sector.

Strong international ADV growth may benefit APAC‑focused broker‑dealers.

CME's record volume underscores continued demand for futures amid global rate uncertainty.

Counterpoint

Despite the beat, the modest margin expansion and rising license fees could pressure earnings if equity volumes cool.

Key entities

  • CME Group Inc

    Global derivatives clearing and market data provider.

Related articles

$RTXHighAI 8/10

Nasdaq and Small Caps Lead Three Day Surge as Crude Slides and Blue Chips Hold Firm

Nasdaq Composite and Russell 2000 led a three-day market rally, with Nasdaq up 2.14% and Russell 2000 up 2.36% for the week. The Dow and S&P 500 also gained over 1.2%. Several companies reported earnings, including RTX (NYSE: RTX), Abbott (NYSE: ABT), CME Group (Nasdaq: CME), M/I Homes (NYSE: MHO), and Lockheed Martin (NYSE: LMT). RTX reported $25.0B in Q3 sales and raised its full-year outlook. Abbott posted 14.5% sales growth. CME Group saw record Q3 revenue.

$CMEMed

CME Group Q3 Earnings Call Highlights

CME Group reported average daily margin savings of over $100 billion in Q3, driven by equities and fixed income. Equities savings totaled $47 billion, while fixed income saw record daily savings. International volume rose 22% to 9 million contracts. New products include Single Stock futures and expanded 24/7 trading. CME expects to launch CME Securities Clearing in December and is testing cloud migration. Pricing changes are expected to increase fees by 0.5% to 1%.

$CMEHighAI 9/10

CME Group Q3 Earnings Surpass Estimates, Revenues Rise Y/Y

CME Group reported Q3 2026 adjusted earnings of $3.02 per share, beating estimates by 1.3% and rising 12.7% year over year. Revenue increased 13% to $1.73 billion, driven by higher fees and trading volumes. Operating income rose 17.3% to $1.14 billion. The company had $23.3 billion in cash and $3.4 billion in long-term debt as of Sept. 30, 2026. CME paid $1 billion in dividends and share repurchases during the quarter.

$CMEHighAI 8/10

[CME Group Q3 2026 Earnings Call] CME Posts Record Q3 Revenue of $1.7B, ADV Jumps 16% to 29.4M Contracts as Q4 Tracking 17% Above Record

CME Group reported record Q3 2026 revenue of $1.7B, up 13%, with average daily volume rising 16% to 29.4M contracts. All asset classes saw double-digit growth, and international participation hit a record 9M contracts. The company expects Q4 to be 17% above record levels, driven by strong market demand and product innovation.

$CMEHighAI 8/10

CME Q3 FY2026 earnings call — BigGo Finance

CME Group reported Q3 FY2026 revenue of $1.7B, up 13% YoY, with record ADV of 29.4M contracts. Adjusted EPS rose 13% to $3.02. All asset classes saw double-digit volume growth. Management expects record 2026 performance and highlighted new products and pricing changes. CME returned nearly $1B to shareholders.